 EL SEGUNDO, Calif. SAN ANTONIO, Texas--BUSINESS WIRE--NantHealth, Inc. NASDAQ: NH, a provider of enterprise solutions that help businesses transform complex data into actionable insights, today presented during a poster session at the San Antonio Breast Cancer Symposium SABCS new significant findings around the adoption of trastuzumab biosimilars in the treatment of HER2-positive breast cancer and the potential clinical and cost benefits of biosimilars. NantHealths presentation demonst 